Spencer C Ian, Li Nianzhen, Chen Qin, Johnson Juliette, Nevill Tanner, Kammonen Juha, Ionescu-Zanetti Cristian
Fluxion Biosciences, Inc., South San Francisco, California 94080, USA.
Assay Drug Dev Technol. 2012 Aug;10(4):313-24. doi: 10.1089/adt.2011.414. Epub 2012 May 10.
Automated patch clamping addresses the need for high-throughput screening of chemical entities that alter ion channel function. As a result, there is considerable utility in the pharmaceutical screening arena for novel platforms that can produce relevant data both rapidly and consistently. Here we present results that were obtained with an innovative microfluidic automated patch clamp system utilizing a well-plate that eliminates the necessity of internal robotic liquid handling. Continuous recording from cell ensembles, rapid solution switching, and a bench-top footprint enable a number of assay formats previously inaccessible to automated systems. An electro-pneumatic interface was employed to drive the laminar flow of solutions in a microfluidic network that delivered cells in suspension to ensemble recording sites. Whole-cell voltage clamp was applied to linear arrays of 20 cells in parallel utilizing a 64-channel voltage clamp amplifier. A number of unique assays requiring sequential compound applications separated by a second or less, such as rapid determination of the agonist EC(50) for a ligand-gated ion channel or the kinetics of desensitization recovery, are enabled by the system. In addition, the system was validated via electrophysiological characterizations of both voltage-gated and ligand-gated ion channel targets: hK(V)2.1 and human Ether-à-go-go-related gene potassium channels, hNa(V)1.7 and 1.8 sodium channels, and (α1) hGABA(A) and (α1) human nicotinic acetylcholine receptor receptors. Our results show that the voltage dependence, kinetics, and interactions of these channels with pharmacological agents were matched to reference data. The results from these IonFlux™ experiments demonstrate that the system provides high-throughput automated electrophysiology with enhanced reliability and consistency, in a user-friendly format.
自动化膜片钳技术满足了对改变离子通道功能的化学实体进行高通量筛选的需求。因此,对于能够快速且一致地产生相关数据的新型平台而言,在药物筛选领域具有相当大的实用价值。在此,我们展示了使用一种创新的微流控自动化膜片钳系统所获得的结果,该系统采用了一种微孔板,无需内部机器人液体处理。对细胞群体进行连续记录、快速溶液切换以及较小的台式占地面积,使得自动化系统以前无法实现的多种检测形式成为可能。采用了一种电动气动接口来驱动微流控网络中溶液的层流,该网络将悬浮细胞输送到群体记录位点。利用一个64通道电压钳放大器对20个细胞的线性阵列并行施加全细胞电压钳。该系统能够实现许多需要在一秒或更短时间内依次施加化合物的独特检测,例如快速测定配体门控离子通道的激动剂EC(50)或脱敏恢复的动力学。此外,通过对电压门控和配体门控离子通道靶点(hK(V)2.1和人类醚 - 去极化相关基因钾通道、hNa(V)1.7和1.8钠通道以及(α1) hGABA(A)和(α1)人类烟碱型乙酰胆碱受体)进行电生理表征,对该系统进行了验证。我们的结果表明,这些通道与药理试剂的电压依赖性、动力学和相互作用与参考数据相符。这些IonFlux™实验的结果表明,该系统以用户友好的形式提供了具有更高可靠性和一致性的高通量自动化电生理学。